Haiming Liu

Area of research

Molecular Biology · Cancer Research

Research interest

Research focused on Downregulation and upregulation and Cancer research, with related work in Multiple drug resistance, MAPK/ERK pathway, MEK inhibitor. Notable publications include 'LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway', 'The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis', and 'DNMT1 expression partially dictates 5-Azacytidine sensitivity and correlates with RAS/MEK/ERK activity in gastric cancer cells'.

h-index

—

citations

233

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

DNMT1 expression partially dictates 5-Azacytidine sensitivity and correlates with RAS/MEK/ERK activity in gastric cancer cells

Epigenetics 2023cited by 13position: middledoi

The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis

Frontiers in Oncology 2021cited by 19position: middledoi

LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway

Cell Death and Differentiation 2020cited by 201position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yongzhan Nie · National Clinical Research Center for Digestive Diseases2 papers (2021–2023)Daiming Fan · Theranostics (New Zealand)2 papers (2021–2023)Jiayi Cao · Ningbo University1 papers (2020–2020)Xin Xie · Fudan University1 papers (2020–2020)Lin Zhang · Guilin Medical University1 papers (2023–2023)Xiaoyu Kang · Inner Mongolia Agricultural University1 papers (2023–2023)Yuying Han · Ministry of Education of the People's Republic of China1 papers (2020–2020)Yanan Han · Technical University of Munich1 papers (2021–2021)Yi Chu · King University1 papers (2020–2020)Yang Yang · Southwest University1 papers (2023–2023)Yuanyuan Lu · China Pharmaceutical University1 papers (2021–2021)Yanhong Liu · Hebei Medical University1 papers (2021–2021)Mingzuo Jiang · Nanjing Medical University1 papers (2020–2020)— · 1 papers (2021–2021)Bing Xu · Shandong University1 papers (2020–2020)Xiangyuan Zhang · Chinese PLA General Hospital1 papers (2021–2021)— · 1 papers (2023–2023)Xiaodi Zhao · Xinjiang University1 papers (2021–2021)— · 1 papers (2021–2021)Rugang Zhang · The University of Texas MD Anderson Cancer Center1 papers (2021–2021)